GENEREX BIOTECHNOLOGY CORP
10-K, EX-23.1, 2000-10-30
PHARMACEUTICAL PREPARATIONS
Previous: GENEREX BIOTECHNOLOGY CORP, 10-K, EX-21, 2000-10-30
Next: GENEREX BIOTECHNOLOGY CORP, 10-K, EX-27, 2000-10-30




<PAGE>


                                  Exhibit 23.1

                        CONSENT OF INDEPENDENT AUDITORS


The Annual Report of Generex Biotechnology Corporation (the Company) for its
fiscal year ended July 31, 2000, includes our report dated September 14, 2000,
except as to Notes 16(D) and 16(E) as to which the dates are September 29, 2000,
and October 5, 2000, respectively, on the consolidated financial statements of
the Company as of July 31, 2000 and 1999 and for the years ended July 31, 2000,
1999, and 1998. We consent to the incorporation by reference of our report on
such consolidated financial statements in the following registration statements
of the Company on Form S-3: registration numbers 333-33556, 333-41062 and
333-42452.


/s/ WithumSmith&Brown
-------------------------
WithumSmith+Brown
New Brunswick, New Jersey
October 30, 2000







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission